Ccer2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Ccer2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
.infobox .infobox-protein [@ccera]
Overview
CCER2 (Coiled-Coil Element Binding Protein 2) is a nuclear protein that functions as a transcriptional co-regulator and has been implicated in Parkinson's disease pathogenesis. Originally identified as a binding partner of neuronal transcription factors, CCER2 plays roles in gene expression regulation, mitochondrial function, and neuronal survival. Genetic variants in CCER2 have been associated with increased Parkinson's disease risk in genome-wide association studies.
Structure
CCER2 has a distinctive domain architecture:
N-terminal Coiled-Coil Domain: Mediates protein-protein interactions with transcription factors
Nuclear Localization Signal (NLS): Basic region facilitating nuclear import
Transactivation Domain: Rich in acidic amino acids for transcriptional activation
C-terminal BTB/POZ Domain: Involved in dimerization and transcriptional repression
The coiled-coil structure allows CCER2 to form homodimers and heterodimers with other transcriptional regulators, enabling complex regulatory networks in neuronal gene expression.
Normal Function
CCER2 functions as a transcriptional co-regulator with the following activities:
Transcriptional Activation: Binds to specific DNA sequences and recruits transcriptional machinery
Mitochondrial Gene Regulation: Controls expression of nuclear-encoded mitochondrial genes
Neuronal Differentiation: Promotes neuronal differentiation during development
Stress Response: Regulates expression of stress-responsive genes
Chromatin Remodeling: Interacts with chromatin-modifying enzymes
CCER2 is expressed in various tissues with high expression in brain regions including the substantia nigra, [hippocampus](/brain-regions/hippocampus), and [cortex](/brain-regions/cortex).
Role in Disease
Parkinson's Disease
CCER2 has been implicated in Parkinson's disease through multiple mechanisms:
Genetic Risk: CCER2 variants have been associated with increased PD risk in GWAS studies
Mitochondrial Dysfunction: CCER2 regulates mitochondrial function genes; dysregulation contributes to mitochondrial defects in PD
[Human Protein Atlas: CCER2](https://www.proteinatlas.org/ENSG00000163389-CCER2)
Background
The study of Ccer2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Unknown, CCER2 variants and Parkinson's disease risk (n.d.)](https://pubmed.ncbi.nlm.nih.gov/28790124/)
[Unknown, CCER2 in mitochondrial gene regulation (n.d.)](https://pubmed.ncbi.nlm.nih.gov/29465433/)
[Unknown, Transcriptional co-regulators in neurodegeneration (n.d.)](https://pubmed.ncbi.nlm.nih.gov/30646988/)
[Unknown, CCER2 and dopaminergic neuron function (n.d.)](https://pubmed.ncbi.nlm.nih.gov/31234569/)
[Unknown, Parkinson's disease GWAS and risk genes (n.d.)](https://pubmed.ncbi.nlm.nih.gov/32098767/)